Delivery Order SPE2DB25D3012-SPE2DB25FWZXP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Welireg 40 mg tablets (90-count units) valued at $17,968.39. This firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,968.39 to AmerisourceBergen Drug Corp for the supply of Welireg 40 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $35,936.78 delivery order to AmerisourceBergen Drug Corp for 90-tablet supplies of Welireg 40 mg, a pharmaceutical product, with performance in Conshohocken, Pennsylvania and completion targeted for September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order executes...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for Welireg 40 mg tablets (90-count packages) with a ceiling value of $17,968.39. This firm fixed-price, non-set-aside contract is scheduled for completion by August 18, 2025, and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,968.39, is for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price contract is for the supply of WELIREG 40 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WELIREG 40 MG TABLET 90S. The contract has a ceiling value of $17,968.39 and an ultimate completion date of July 3, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $34,736.28 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product, to support military treatment programs and facilities. The award has an ultimate completion date of September 26, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WELIREG 40 MG TABLET 90S. The firm-fixed-price contract has a ceiling value of $17,968.39 and an ultimate completion date of June 18, 2025. The award is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive global...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,936.78, is for the delivery of WELIREG 40 MG TABLET 90S. The award has an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp is the prime contractor for this delivery order. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZXPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Welireg 40 mg tablets (90-count) with a ceiling value of $17,968.39. This firm fixed-price delivery order, with an ultimate completion date of October 1, 2025, represents a non-competitive, competitively awarded contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The DLA Troop Support Medical is establishing Pharmaceutical Prime Vendor Global Program Generation V contracts with plans for multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 9/10/25 |